Literature DB >> 11171210

Properties and inhibition of the first two enzymes of the non-mevalonate pathway of isoprenoid biosynthesis.

C Mueller1, J Schwender, J Zeidler, H K Lichtenthaler.   

Abstract

Enzymes of the 1-deoxy-D-xylulose 5-phosphate/2-C-methylerythritol 4-phosphate (DOXP/MEP) pathway are targets for new herbicides and antibacterial drugs. Until now, no inhibitors for the DOXP synthase have been known of. We show that one of the breakdown products of the herbicide clomazone affects the DOXP synthase. One inhibitor of the non-mevalonate pathway, fosmidomycin, blocks the DOXP reductoisomerase (DXR) of plants and bacteria. The I(50) values of plants are, however, higher than those found for the DXR of Escherichia coli. The DXR of plants, isolated from barley seedlings, shows a pH optimum of 8.1, which is typical for enzymes active in the chloroplast stroma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11171210

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  30 in total

1.  Functional microdomains in bacterial membranes.

Authors:  Daniel López; Roberto Kolter
Journal:  Genes Dev       Date:  2010-08-16       Impact factor: 11.361

2.  A whole-cell phenotypic screening platform for identifying methylerythritol phosphate pathway-selective inhibitors as novel antibacterial agents.

Authors:  Charles A Testa; L Jeffrey Johnson
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

3.  1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.

Authors:  Rakesh K Dhiman; Merrill L Schaeffer; Ann Marie Bailey; Charles A Testa; Hataichanok Scherman; Dean C Crick
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 4.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

5.  Toward Mycobacterium tuberculosis DXR inhibitor design: homology modeling and molecular dynamics simulations.

Authors:  Nidhi Singh; Mitchell A Avery; Christopher R McCurdy
Journal:  J Comput Aided Mol Des       Date:  2007-09-14       Impact factor: 3.686

6.  Theileria apicoplast as a target for chemotherapy.

Authors:  Regina Lizundia; Dirk Werling; Gordon Langsley; Stuart A Ralph
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

Review 7.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

8.  Divergent regulation of terpenoid metabolism in the trichomes of wild and cultivated tomato species.

Authors:  Katrin Besser; Andrea Harper; Nicholas Welsby; Ines Schauvinhold; Stephen Slocombe; Yi Li; Richard A Dixon; Pierre Broun
Journal:  Plant Physiol       Date:  2008-11-07       Impact factor: 8.340

9.  Effects of brassinazole, an inhibitor of brassinosteroid biosynthesis, on light- and dark-grown Chlorella vulgaris.

Authors:  Andrzej Bajguz; Tadao Asami
Journal:  Planta       Date:  2003-12-04       Impact factor: 4.116

10.  Distinct light-mediated pathways regulate the biosynthesis and exchange of isoprenoid precursors during Arabidopsis seedling development.

Authors:  Manuel Rodríguez-Concepción; Oriol Forés; Jaime F Martinez-García; Victor González; Michael A Phillips; Albert Ferrer; Albert Boronat
Journal:  Plant Cell       Date:  2003-12-05       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.